Abstract: The present specification provides, inter alia, methods of using Wnt and FZD proteins, genes, FZD and Wnt-specific antibodies and probes in diagnosis and treatment of cancer and for screening test compounds for an ability to treat cancer. Also disclosed are compounds useful for treating cancer such as liver cancer.
Abstract: Renal injury and inflammation is diagnosed by detecting an elevation in GSK3b level or activity. Inflammation of bodily tissues such as renal tissue is inhibited by administration of GSK3b inhibitory compositions.
Abstract: The invention features a tribonectin and a method of tribosupplementation carried out by administering tribonectins directly to an injured or arthritic joint.
Abstract: Compositions and methods for detecting sepsis by contacting a subject-derived sample with a ligand that binds to GRK and determining the concentration of GRK in the sample. An increase in the concentration of GRK compared to that of a normal, healthy control sample indicates that the subject from which the sample is obtained is suffering from or at risk of developing sepsis.
Abstract: The invention provides a primary liver stem cell and a cell doublet consisting of a hepatocyte and the stem cell, both of which are derived from normal liver tissue. Methods of isolating the cells, genetically altering the cells, and using the cells for transplantation are also within the invention.
Type:
Grant
Filed:
January 19, 2005
Date of Patent:
May 3, 2011
Assignee:
Rhode Island Hospital, a Lifespan Partner
Abstract: An implant system and apparatus configured to permit motion of the wrist in at least one physiological direction, as well as in a dart thrower's motion, and constrain motion of the wrist in at least one non-physiological direction are provided. The implant according to one embodiment includes a distal component and proximal component. Each of the distal and proximal components includes a primary articulating portion and a secondary articulating portion. Primary and secondary articulating portions include at least one component having either a substantially convex or a substantially concave shape. The secondary articulating portion is configured to be radially and volarly disposed in relation to the primary articulating portion.
Type:
Grant
Filed:
April 15, 2009
Date of Patent:
April 5, 2011
Assignees:
New York Society for the Ruptured and Crippled Maintaining the Hospital for Special Surgery, Rhode Island Hospital
Inventors:
Scott W. Wolfe, Joseph John Crisco, III
Abstract: An implant system and apparatus configured to permit motion of the wrist in at least one physiological direction, as well as in a dart thrower's motion, and constrain motion of the wrist in at least one non-physiological direction are provided. The implant according to one embodiment includes a distal component and proximal component. Each of the distal and proximal components includes a primary articulating portion and a secondary articulating portion. Primary and secondary articulating portions include at least one component having either a substantially convex or a substantially concave shape. The secondary articulating portion is configured to be radially and volarly disposed in relation to the primary articulating portion.
Type:
Grant
Filed:
May 4, 2009
Date of Patent:
March 29, 2011
Assignees:
New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgey, Rhode Island Hospital
Inventors:
Scott W. Wolfe, Joseph John Crisco, III
Abstract: The present specification provides, inter alia, methods of using Wnt and FZD proteins, genes, FZD and Wnt-specific antibodies and probes in diagnosis and treatment of cancer and for screening test compounds for an ability to treat cancer. Also disclosed are compounds useful for treating cancer such as liver cancer.
Type:
Grant
Filed:
January 5, 2005
Date of Patent:
January 11, 2011
Assignee:
Rhode Island Hospital, a Lifespan-Partner
Inventors:
Jack R. Wands, Philippe Merle, Suzanne M. De La Monte
Abstract: This invention relates to methods for diagnosing Alzheimer's Disease (AD) by determining the level or function of insulin, insulin-like growth factors, their receptors and/or their downstream signaling molecules. The invention further relates to methods for the treatment of AD by administering an insulin agonist and an insulin-like growth factor agonist. The invention additionally provides an animal model of AD and methods of screening for agents useful in the treatment, amelioration, or prevention of AD.
Type:
Grant
Filed:
March 31, 2006
Date of Patent:
November 16, 2010
Assignee:
Rhode Island Hospital
Inventors:
Suzanne Marie de la Monte, Jack Raymond Wands
Abstract: The invention provides methods of identifying metastatic disease as well as ligands such as antibodies that bind to GPR30. These antibodies are useful in the detection or treatment of endocrine tumors.
Abstract: The invention features a tribonectin and a method of tribosupplementation carried out by administering tribonectins directly to an injured or arthritic joint.
Abstract: The present specification provides, inter alia, methods of using Wnt and FZD proteins and genes, and Wnt- and FZD-specific antibodies and probes in diagnosis and treatment of cancer and for screening test compounds for an ability to treat cancer. Also disclosed are compounds useful for treating cancer such as liver cancer.
Type:
Application
Filed:
February 5, 2010
Publication date:
August 12, 2010
Applicant:
RHODE ISLAND HOSPITAL, A LIFESPAN-PARTNER
Abstract: A method of prognosis for ovarian or breast cancer patients is carried out by detecting GPR30 in a sample of tissue. An elevation in the level of GPR30 compared to a normal control level indicates presentation of late stage disease and indicates responsiveness of the tumor to hormonal therapy.
Abstract: The invention features a method for diagnosing and inhibiting growth of a malignant neoplasm in a mammal by contacting a cell or a bodily fluid of the mammal with an antibody which binds to an human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide. Methods of immunization to generate an HAAH-specific immune response are also within the invention.
Type:
Application
Filed:
December 21, 2009
Publication date:
July 8, 2010
Applicant:
RHODE ISLAND HOSPITAL
Inventors:
JACK R. WANDS, SUZANNE M. DE LA MONTE, ALAN H. DEUTCH, HOSSEIN A. GHANBARI
Abstract: The invention features a method for diagnosing a malignant neoplasm in a mammal by contacting a bodily fluid from the mammal with an antibody which binds to an human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide and methods of treating malignant neoplasms by inhibiting HAAH.
Type:
Application
Filed:
November 25, 2009
Publication date:
June 10, 2010
Applicant:
Rhode Island Hospital
Inventors:
Jack R. Wands, Suzanne M. de la Monte, Nedim Ince, Rolf I. Carlson
Abstract: The invention features a method for diagnosing a malignant neoplasm in a mammal by contacting a bodily fluid from the mammal with an antibody which binds to an human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide and methods of treating malignant neoplasms by inhibiting HAAH.
Type:
Application
Filed:
November 25, 2009
Publication date:
June 3, 2010
Applicant:
Rhode Island Hospital
Inventors:
Jack R. Wands, Suzanne M. de la Monte, Nedim Ince, Rolf I. Carlson
Abstract: A method of estimating an amount of a substance in a bodily fluid from the color of a tissue surface of a subject includes capturing an image including at least a portion-of-interest of the subject and at least a reference portion of a color reference, the image being a digital image of pixels of at least one color, the image including a component value for each pixel for each of the at least one color, obtaining a first value associated with at least one component value corresponding to the portion-of-interest of the subject, obtaining a second value associated with at least one component value corresponding to the reference portion, and calculating an estimated amount of the substance using the first and second values.
Type:
Grant
Filed:
April 4, 2002
Date of Patent:
May 4, 2010
Assignee:
Rhode Island Hospital
Inventors:
Gregory D. Jay, Selim Suner, Kevin S. Ernsting
Abstract: The invention features a tribonectin and a method of tribosupplementation carried out by administering tribonectins directly to an injured or arthritic joint.
Abstract: The invention relates to topical compositions comprising a fluorescent dye that absorbs UVA and UVB radiation and converts it into a healing light, in combination with a dermatologically acceptable excipient. The compositions of the invention are useful for repairing photo-damaged skin cells and reducing or preventing future skin damage as a result of exposure to UV light.
Abstract: The invention features a tribonectin and a method of tribosupplementation carried out by administering tribonectins directly to an injured or arthritic joint.